Pacific Biosciences
PACB
PACB
225 hedge funds and large institutions have $475M invested in Pacific Biosciences in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 75 increasing their positions, 65 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
9% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 35
0% less funds holding
Funds holding: 226 → 225 (-1)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
225
Holding in Top 10
2
Calls
$6.83M
Puts
$4.17M
Top Buyers
| 1 | +$37.4M | |
| 2 | +$12.2M | |
| 3 | +$8.96M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$4.83M |
| 5 |
Morgan Stanley
New York
|
+$3.22M |
Top Sellers
| 1 | -$5.76M | |
| 2 | -$4.42M | |
| 3 | -$4.11M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.79M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$3.09M |